PDS Biotechnology (PDSB) EPS (Basic) (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly EPS (Basic) came in at -$0.0 in Q4 2025, up 99.28% YoY from -$0.0 in Q4 2024, and up 99.18% on a QoQ basis from -$0.19 in Q3 2025.
PDS Biotechnology (PDSB) EPS (Basic) (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 12 years of EPS (Basic) data on file, last reported at -$0.0 in Q4 2025.
- Quarterly EPS (Basic) rose 99.28% year-over-year to -$0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.58 (up 43.57% YoY) and the FY2025 annual result came in at -$0.61, up 41.13% from the prior year.
- EPS (Basic) advanced to -$0.0 in Q4 2025, from -$0.19 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q4 2025 to a low of -$0.67 in Q4 2022.
- A 5-year average of -$0.27 and a median of -$0.25 in 2021 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 704.34% — and 2025, when it soared 99.28%.
- Tracing PDSB's EPS (Basic) over 5 years: stood at -$0.25 in 2021, then tumbled by 171.04% to -$0.67 in 2022, then soared by 47.39% to -$0.35 in 2023, then jumped by 38.04% to -$0.22 in 2024, then soared by 99.28% to -$0.0 in 2025.
- The last three EPS (Basic) figures came in at -$0.0 (Q4 2025), -$0.19 (Q3 2025), and -$0.21 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.29 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -0.37 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.67 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.20 |
| Mar 31, 2022 | -0.57 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.03 |